AI assistant
METLIFE INC — Director's Dealing 2021
Feb 25, 2021
29995_dirs_2021-02-25_742e331b-674b-48b4-91f0-54bd7778623d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2021-02-23
Reporting Person: PODLOGAR SUSAN M (EVP & Chief HR Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-23 | Common Stock | A | 3918 | — | Acquired | 28044 | Direct |
| 2021-02-23 | Common Stock | A | 8523 | — | Acquired | 36567 | Direct |
| 2021-02-23 | Common Stock | F | 2934 | $57.43 | Disposed | 33633 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-23 | Employee Stock Options (right to buy) | $57.43 | A | 11756 | Acquired | 2031-02-22 | Common Stock (11756.0) | Direct |
Footnotes
F1: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2: Includes 7,337 restricted stock units previously reported on Table II.
F3: Shares acquired from the determination of the performance factor for and payout of 2018-2020 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation.
F4: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F5: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.